CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

The CEO of UnitedHealth Group said Thursday that shortcomings of America’s health care system must be addressed.

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target ...

Presentation Operator Good morning, and welcome to UnitedHealth Group Fourth Quarter and Full Year 2024 Earnings Conference ...

We came across a bullish thesis on The Cigna Group (CI) on Twitter by Tsachy Mishal. In this article, we will summarize the ...

Sarah James; Analyst; Cantor Fitzgerald Joanna Gajuk; Analyst; BofA Global Research ...

As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...

Wells Fargo analyst Stephen Baxter maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of ...

When considering the health care enforcement landscape in 2024 and where it might be headed in 2025, we would be remiss if we ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf testifies before a House Appropriations Subcommittee hearing on President Biden's proposed budget request for the FDA for fiscal ...

President Joe Biden signed a bill on Sunday that will repeal two laws previously preventing many public employees from receiving Social Security benefits. The Social Security Fairness Act, which ...